POMC and pituitary tumor: Indeed, considering that a significant percentage of human corticotropic adenomas responsible for CD and several extra-pituitary tumors express D2 dopamine receptors, which play a key role in the control of ACTH secretion and tumor growth, cabergoline and other dopaminergic drugs can be used as first therapeutic options or adjuvants in the case of surgery contraindications or refusal.